纹理乳房假体更换中包膜切除术必要性的评估
结论认为包膜切除术增加手术风险、不适、恢复时间和费用,对无症状患者并非必需;仅在存在包膜病理症状或诊断为BIA-ALCL时推荐行包膜切除术或整块切除。
要点
- 无症状纹理假体患者更换假体时,不联合包膜切除术是可接受的选择。
- 包膜切除术增加手术风险、不适、恢复时间和费用,并非无症状患者必需。
- 整块切除仅推荐用于确诊BIA-ALCL的患者,无症状患者不推荐预防性包膜切除。
核心结论
- 包膜切除术增加并发症风险,对无症状患者并非必需。
- 无症状且无包膜病理的患者,可考虑不联合包膜切除术而直接移除或更换为光面假体。
- 任何提示病理的症状或术中发现均应行包膜切除术。
- 整块切除仅用于确诊BIA-ALCL的患者。
主要发现
- 包膜切除术被广泛推荐用于治疗包膜挛缩,但许多作者建议无症状时可保留薄层包膜组织。
- 整块切除仅推荐用于确诊BIA-ALCL的女性。
- 无证据支持对无症状纹理假体女性行预防性包膜切除术以降低BIA-ALCL风险。
- 无症状患者常规病理检查不受支持。
关键数值与推荐
- 包膜切除术广泛推荐用于治疗包膜挛缩。
- 整块切除仅推荐用于确诊BIA-ALCL的患者。
- 无症状患者不推荐预防性包膜切除,也不支持常规病理检查。
临床怎么用
- 对无症状纹理假体患者,可考虑不联合包膜切除术直接移除或更换为光面假体。
- 出现任何提示病理的症状或术中发现时,应行包膜切除术。
- 确诊BIA-ALCL的患者应行整块切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Capsulectomy has traditionally been recommended as a treatment for capsular contracture after breast augmentation. With the advent of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), and the Food and Drug Administration's decision to ban Biocell textured devices, this operation has taken on new importance. This review was undertaken to better inform clinical recommendations for women with textured devices. METHODS: An electronic search was performed using PubMed to identify all the available literature on the subject of capsulectomy and open capsulotomy (the alternative treatment). RESULTS: Fifty-seven articles on this topic were identified. Capsulectomy was widely recommended for treatment of capsular contracture, although many authors recommended leaving thin capsular tissue behind in the absence of symptoms. En bloc resection was recommended only for women with a diagnosis of BIA-ALCL. No information supported a prophylactic role for capsulectomy in asymptomatic women with textured breast implants who are concerned regarding their future risk of BIA-ALCL. Routine pathologic examination in asymptomatic patients was not supported. DISCUSSION: Capsulectomy adds substantially to the surgical risk, discomfort, recovery time, and expense. Implant removal or replacement without a simultaneous capsulectomy is atraumatic and poses negligible risk. CONCLUSIONS: Capsulectomy introduces additional morbidity and is not mandatory for asymptomatic patients. Implant removal or exchange for smooth implants without a capsulectomy may be an acceptable choice for many women who do not demonstrate capsular pathology. However, any symptoms or surgical findings suggesting pathology warrant a capsulectomy. En bloc resections are reserved for patients diagnosed with BIA-ALCL.
引用
- Swanson E. Evaluating the Necessity of Capsulectomy in Cases of Textured Breast Implant Replacement. Ann Plast Surg. 2020. PMID: 32102001. doi:10.1097/SAP.0000000000002301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。